Published in Nat Biotechnol on January 26, 2014
Development and applications of CRISPR-Cas9 for genome engineering. Cell (2014) 13.50
CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol (2014) 9.18
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System. Cell (2015) 5.97
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol (2014) 5.69
In vivo genome editing using Staphylococcus aureus Cas9. Nature (2015) 5.26
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol (2014) 4.41
Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature (2015) 3.77
Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat Biotechnol (2014) 3.72
Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat Biotechnol (2014) 3.66
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature (2016) 3.54
Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res (2014) 3.31
Rationally engineered Cas9 nucleases with improved specificity. Science (2015) 3.14
Optimized CRISPR/Cas tools for efficient germline and somatic genome engineering in Drosophila. Proc Natl Acad Sci U S A (2014) 2.97
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat Biotechnol (2014) 2.75
Concerning RNA-guided gene drives for the alteration of wild populations. Elife (2014) 2.69
Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy. Nat Commun (2015) 2.56
Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. Cell Stem Cell (2014) 2.55
Therapeutic genome editing: prospects and challenges. Nat Med (2015) 2.42
High-throughput functional genomics using CRISPR-Cas9. Nat Rev Genet (2015) 2.35
A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae. Nat Biotechnol (2015) 2.21
Characterization of genomic deletion efficiency mediated by clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells. J Biol Chem (2014) 2.18
Small molecule-triggered Cas9 protein with improved genome-editing specificity. Nat Chem Biol (2015) 2.13
RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature (2014) 2.03
Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res (2014) 1.96
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA. Genome Res (2014) 1.91
CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo. Nat Methods (2015) 1.88
A mouse geneticist's practical guide to CRISPR applications. Genetics (2014) 1.81
Targeted genomic rearrangements using CRISPR/Cas technology. Nat Commun (2014) 1.70
Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing. J Assist Reprod Genet (2016) 1.64
Sequence determinants of improved CRISPR sgRNA design. Genome Res (2015) 1.56
sgRNAcas9: a software package for designing CRISPR sgRNA and evaluating potential off-target cleavage sites. PLoS One (2014) 1.54
Unraveling CRISPR-Cas9 genome engineering parameters via a library-on-library approach. Nat Methods (2015) 1.53
Efficient gene editing in tomato in the first generation using the clustered regularly interspaced short palindromic repeats/CRISPR-associated9 system. Plant Physiol (2014) 1.53
CRISPR multitargeter: a web tool to find common and unique CRISPR single guide RNA targets in a set of similar sequences. PLoS One (2015) 1.51
Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. Nat Biotechnol (2015) 1.41
Genome-editing Technologies for Gene and Cell Therapy. Mol Ther (2016) 1.41
A CRISPR view of development. Genes Dev (2014) 1.41
Mutations in KEOPS-complex genes cause nephrotic syndrome with primary microcephaly. Nat Genet (2017) 1.39
Making designer mutants in model organisms. Development (2014) 1.38
Protospacer adjacent motif (PAM)-distal sequences engage CRISPR Cas9 DNA target cleavage. PLoS One (2014) 1.38
Enhanced specificity and efficiency of the CRISPR/Cas9 system with optimized sgRNA parameters in Drosophila. Cell Rep (2014) 1.35
Conformational control of DNA target cleavage by CRISPR-Cas9. Nature (2015) 1.35
Applications of CRISPR technologies in research and beyond. Nat Biotechnol (2016) 1.34
Efficient CRISPR-Cas9-mediated genome editing in Plasmodium falciparum. Nat Methods (2014) 1.31
Targeted genome modifications in soybean with CRISPR/Cas9. BMC Biotechnol (2015) 1.28
Genome engineering with CRISPR-Cas9 in the mosquito Aedes aegypti. Cell Rep (2015) 1.28
High-throughput mapping of regulatory DNA. Nat Biotechnol (2016) 1.27
International regulatory landscape and integration of corrective genome editing into in vitro fertilization. Reprod Biol Endocrinol (2014) 1.27
Editing the epigenome: technologies for programmable transcription and epigenetic modulation. Nat Methods (2016) 1.24
Efficient chromosomal gene modification with CRISPR/cas9 and PCR-based homologous recombination donors in cultured Drosophila cells. Nucleic Acids Res (2014) 1.23
Target specificity of the CRISPR-Cas9 system. Quant Biol (2014) 1.23
Off-target Effects in CRISPR/Cas9-mediated Genome Engineering. Mol Ther Nucleic Acids (2015) 1.23
A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture. Nucleic Acids Res (2015) 1.20
Applications of CRISPR-Cas systems in neuroscience. Nat Rev Neurosci (2015) 1.18
CRISPR-Cas9-mediated single-gene and gene family disruption in Trypanosoma cruzi. MBio (2014) 1.17
TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity. Nucleic Acids Res (2014) 1.16
Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9. J Clin Invest (2014) 1.13
CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems. PLoS One (2014) 1.11
Advances in genome editing technology and its promising application in evolutionary and ecological studies. Gigascience (2014) 1.11
RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection. Proc Natl Acad Sci U S A (2014) 1.10
Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference. Nucleic Acids Res (2015) 1.10
CRISPR-Cas9-assisted recombineering in Lactobacillus reuteri. Nucleic Acids Res (2014) 1.10
Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications. Genome Biol (2015) 1.10
Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR. Mol Cell (2015) 1.09
A CRISPR-Cas9 System for Genetic Engineering of Filamentous Fungi. PLoS One (2015) 1.08
Multiplexed labeling of genomic loci with dCas9 and engineered sgRNAs using CRISPRainbow. Nat Biotechnol (2016) 1.08
CRISPR/Cas-mediated genome editing in the rat via direct injection of one-cell embryos. Nat Protoc (2014) 1.08
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes. Cell (2016) 1.08
Efficient inversions and duplications of mammalian regulatory DNA elements and gene clusters by CRISPR/Cas9. J Mol Cell Biol (2015) 1.07
Induced Pluripotent Stem Cells Meet Genome Editing. Cell Stem Cell (2016) 1.06
Whole-organism lineage tracing by combinatorial and cumulative genome editing. Science (2016) 1.06
Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells. Nat Biotechnol (2016) 1.06
Induction of targeted, heritable mutations in barley and Brassica oleracea using RNA-guided Cas9 nuclease. Genome Biol (2015) 1.06
Cas9 gRNA engineering for genome editing, activation and repression. Nat Methods (2015) 1.04
Dimeric CRISPR RNA-Guided FokI-dCas9 Nucleases Directed by Truncated gRNAs for Highly Specific Genome Editing. Hum Gene Ther (2015) 1.04
Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases. Nat Rev Genet (2016) 1.03
Mouse genome engineering via CRISPR-Cas9 for study of immune function. Immunity (2015) 1.02
Chromatin regulation at the frontier of synthetic biology. Nat Rev Genet (2015) 1.01
Systematic Evaluation of Drosophila CRISPR Tools Reveals Safe and Robust Alternatives to Autonomous Gene Drives in Basic Research. G3 (Bethesda) (2015) 1.01
Genome-wide target specificities of CRISPR-Cas9 nucleases revealed by multiplex Digenome-seq. Genome Res (2016) 1.01
Spell Checking Nature: Versatility of CRISPR/Cas9 for Developing Treatments for Inherited Disorders. Am J Hum Genet (2015) 1.00
Synthetic epigenetics-towards intelligent control of epigenetic states and cell identity. Clin Epigenetics (2015) 0.99
The CRISPR/Cas Genome-Editing Tool: Application in Improvement of Crops. Front Plant Sci (2016) 0.99
Targeted mutagenesis in soybean using the CRISPR-Cas9 system. Sci Rep (2015) 0.98
Orthogonal gene knockout and activation with a catalytically active Cas9 nuclease. Nat Biotechnol (2015) 0.98
Multi-input CRISPR/Cas genetic circuits that interface host regulatory networks. Mol Syst Biol (2014) 0.98
Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9. Mol Cells (2015) 0.97
Efficient Generation of Myostatin Knock-Out Sheep Using CRISPR/Cas9 Technology and Microinjection into Zygotes. PLoS One (2015) 0.97
Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery. Nat Methods (2015) 0.96
Quantitative CRISPR interference screens in yeast identify chemical-genetic interactions and new rules for guide RNA design. Genome Biol (2016) 0.96
Efficient genome editing in filamentous fungus Trichoderma reesei using the CRISPR/Cas9 system. Cell Discov (2015) 0.95
CRISPR-Cas9 Genome Editing in Drosophila. Curr Protoc Mol Biol (2015) 0.95
Targeted mutagenesis of the tomato PROCERA gene using transcription activator-like effector nucleases. Plant Physiol (2014) 0.95
Stem cells for investigation and treatment of inherited retinal disease. Hum Mol Genet (2014) 0.94
Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection. Sci Rep (2015) 0.94
Modulating the Cascade architecture of a minimal Type I-F CRISPR-Cas system. Nucleic Acids Res (2016) 0.94
Determining the specificities of TALENs, Cas9, and other genome-editing enzymes. Methods Enzymol (2014) 0.93
Engineering synthetic TALE and CRISPR/Cas9 transcription factors for regulating gene expression. Methods (2014) 0.93
CRISPR-Cas: biology, mechanisms and relevance. Philos Trans R Soc Lond B Biol Sci (2016) 0.93
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol (2009) 235.12
Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53
RNA-guided human genome engineering via Cas9. Science (2013) 48.29
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science (2012) 48.17
One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell (2013) 24.00
DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol (2013) 19.99
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol (2013) 18.01
RNA-guided genetic silencing systems in bacteria and archaea. Nature (2012) 17.12
Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell (2013) 13.43
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell (2013) 13.37
FLASH assembly of TALENs for high-throughput genome editing. Nat Biotechnol (2012) 12.97
Genome-scale CRISPR-Cas9 knockout screening in human cells. Science (2013) 12.36
CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol (2013) 11.35
Genetic screens in human cells using the CRISPR-Cas9 system. Science (2013) 10.75
CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell (2013) 9.55
High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol (2013) 8.40
Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. Nat Methods (2011) 6.90
Cas9 as a versatile tool for engineering biology. Nat Methods (2013) 6.87
Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res (2013) 6.19
A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries. Genome Biol (2011) 5.11
RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods (2013) 4.85
CRISPR RNA-guided activation of endogenous human genes. Nat Methods (2013) 4.69
Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system. Proc Natl Acad Sci U S A (2013) 4.57
Positive and negative regulation of endogenous genes by designed transcription factors. Proc Natl Acad Sci U S A (2000) 3.92
ZiFiT (Zinc Finger Targeter): an updated zinc finger engineering tool. Nucleic Acids Res (2010) 3.59
Zinc Finger Targeter (ZiFiT): an engineered zinc finger/target site design tool. Nucleic Acids Res (2007) 3.47
Precision genome engineering with programmable DNA-nicking enzymes. Genome Res (2012) 3.05
Heritable and precise zebrafish genome editing using a CRISPR-Cas system. PLoS One (2013) 2.74
In silico abstraction of zinc finger nuclease cleavage profiles reveals an expanded landscape of off-target sites. Nucleic Acids Res (2013) 1.46
Biotechnology: Rewriting a genome. Nature (2013) 1.27